Client 1st Advisory Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Client 1st Advisory Group's MRK Position: Q2 2026 in Review
Client 1st Advisory Group reduced its Merck (MRK) stake by 16% in Q2 2026, selling an estimated $47.6K and leaving 2,189 shares worth $281K. The position accounts for 0.07% of the portfolio, ranked #117.
Client 1st Advisory Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $312K in Q1 2026. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Client 1st Advisory Group held 2,189 shares of Merck worth $281K as of Q2 2026.
- Client 1st Advisory Group sold 407 Merck shares in Q2 2026, an estimated $47.6K.
- Merck made up 0.07% of Client 1st Advisory Group's portfolio in Q2 2026, its #117 holding.
- Client 1st Advisory Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
- Client 1st Advisory Group's Merck position peaked at $312K in Q1 2026.
- 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Client 1st Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.